Interleukin 17a Antikörper (Middle Region)
-
- Target Alle Interleukin 17a (IL17A) Antikörper anzeigen
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
-
Bindungsspezifität
- AA 60-87, Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Interleukin 17a Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Interleukin-17A (IL17A).
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human
- Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
- Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 60-87aa) of human Interleukin-17A (IL17A).
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product IL17A Primärantikörper
-
anti-Interleukin 17A (IL17A) antibody
IL17A Reaktivität: Ratte ELISA, WB, IHC, Neut, RIA Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 17A (IL17A) (Internal Region) antibodyIL17A Reaktivität: Human, Maus, Ratte ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 17A (IL17A) antibodyIL17A Reaktivität: Human ELISA, WB, Neut Wirt: Ziege Polyclonal unconjugated
anti-Interleukin 17A (IL17A) antibodyIL17A Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 17A (IL17A) antibodyIL17A Reaktivität: Human ELISA, FACS, ICC, IP Wirt: Maus Monoclonal 9F9 unconjugated
anti-Interleukin 17A (IL17A) antibody (FITC)IL17A Reaktivität: Human FACS Wirt: Maus Monoclonal 9F9 FITC
anti-Interleukin 17A (IL17A) antibody (APC)IL17A Reaktivität: Human FACS Wirt: Maus Monoclonal 9F9 APC
anti-Interleukin 17A (IL17A) antibody (PE)IL17A Reaktivität: Human FACS Wirt: Maus Monoclonal 9F9 PE
anti-Interleukin 17A (IL17A) (AA 24-133) antibodyIL17A Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 3G5 unconjugated
anti-Interleukin 17A (IL17A) (AA 24-155) antibodyIL17A Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
- Andere Bezeichnung
- Interleukin-17A (IL17A) (IL17A Produkte)
- Synonyme
- CTLA8 antikoerper, IL-17 antikoerper, IL-17A antikoerper, IL17 antikoerper, Ctla-8 antikoerper, Ctla8 antikoerper, Il17 antikoerper, ChIL-17 antikoerper, IL-17F antikoerper, IL17A antikoerper, CTLA-8 antikoerper, interleukin 17A antikoerper, IL17A antikoerper, Il17a antikoerper
- Hintergrund
- The protein encoded by the IL17A gene is a proinflammatory cytokine produced by activated T cells. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.Synonyms: CTLA-8, CTLA8, Cytotoxic T-lymphocyte-associated antigen 8, IL-17, IL-17A, IL17
- Gen-ID
- 3605
- NCBI Accession
- NP_002181
-
